Nov 14, 2025
Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2025
Complex generic drugs face major scientific and regulatory hurdles that make approval far harder than for simple generics. Despite high demand and patent expirations, few reach the market due to technical challenges, unclear FDA guidance, and high development costs.
